Loading clinical trials...
Loading clinical trials...
Early Neurophysiological Markers of Language Impairments: a Longitudinal Study on Infants At Familial Risk
The present project aims at identifying very early electrophysiological risk markers for language impairments. The long-term goals of the study include the characterization of learning developmental trajectories in children at high risk for language impairments. In this project, all the infants of the Medea BabyLab cohort are followed-up until school age. Since these infants have complete information on early electrophysiological markers, the final goal of the project is the characterization of their learning developmental trajectories and the construction of a multi-factor prognostic model that includes the neurophysiological processes underlying basic-level skills as potential biomarkers for predicting later reading and spelling skills.
Age
0 - 8 years
Sex
ALL
Healthy Volunteers
Yes
Associazione La Nostra Famiglia - IRCCS Eugenio Medea
Bosisio Parini, LC, Italy
Start Date
February 21, 2022
Primary Completion Date
December 31, 2026
Completion Date
December 31, 2026
Last Updated
February 5, 2025
100
ESTIMATED participants
Electrophysiological recording
OTHER
Behavioral assessment
BEHAVIORAL
Lead Sponsor
IRCCS Eugenio Medea
NCT05843396
NCT05678634
NCT06660108
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions